PROQR THERAPEUTICS NV (PRQR)

NL0010872495 - Common Stock

1.94  -0.02 (-1.02%)

After market: 1.98 +0.04 (+2.06%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
9.53M4.80M2.40M9.45M1.93M
Minority Interest Expense
-384.00K-220.00K60.00K50.00K270.00K
Operating Expenses
41.38M69.52M59.59M51.82M59.38M
Research and Development
23.15M48.78M40.53M36.35M44.91M
Selling, General, and Administrative Expenses
15.72M18.22M16.73M13.12M12.42M
Operating Income
-31.86M-64.72M-57.19M-42.37M-57.45M
Interest Income/Expense
2.09M1.31M-4.37M-4.12M830.00K
Other Income/Expense
0.00N/A510.00KN/AN/A
Non Recurring Items
1.87M-1.39MN/AN/AN/A
Income Before Taxes
-27.81M-64.80M-61.56M-46.49M-56.61M
Income Tax
-78.00K100.00K120.00K120.00K130.00K
Net Income
-28.12M-65.11M-61.62M-46.57M-56.48M
EBITDA
-29.35M-62.20M-54.86M-40.01M-55.40M
 
Per Share Data
EPS Diluted Total Ops
-0.35-0.91-0.96-0.93-1.38
Non GAAP EPS
-0.35-0.91-0.97-0.92-1.38
 
Statistics
Profit Margin
-295.21%-1356.46%-2567.50%-492.80%-2926.42%
Operating Profit Margin
-334.48%-1348.33%-2382.92%-448.36%-2976.68%

All data in EUR

Charts